$229 Million is the total value of Grace Capital's 77 reported holdings in Q3 2016. The portfolio turnover from Q2 2016 to Q3 2016 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| VRX | Valeant Pharmaceuticals | $307,000 | +21.8% | 12,517 | 0.0% | 0.13% | +26.4% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2016-10-04
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| SHERWIN WILLIAMS CO | 35 | Q4 2021 | 2.6% |
| JOHNSON & JOHNSON COM | 35 | Q4 2021 | 2.7% |
| GRACO INC | 35 | Q4 2021 | 1.8% |
| EXXON MOBIL CORPORATION COM | 35 | Q4 2021 | 2.0% |
| ALTRIA GROUP INC COM | 34 | Q4 2021 | 2.0% |
| COLGATE-PALMOLIVE CO COM | 34 | Q4 2021 | 2.0% |
| US Physical Therapy Inc. | 34 | Q4 2021 | 1.5% |
| Fiserv Inc. | 32 | Q1 2021 | 2.5% |
| AVERY DENNISON CORP. | 32 | Q4 2021 | 2.2% |
| APPLE INC COM | 31 | Q4 2021 | 5.2% |
View Grace Capital's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2022-02-02 |
| 13F-HR | 2021-11-08 |
| 13F-HR | 2021-08-11 |
| 13F-HR | 2021-05-06 |
| 13F-HR | 2021-02-10 |
| 13F-HR | 2020-11-12 |
| 13F-HR | 2020-08-13 |
| 13F-HR | 2020-05-12 |
| 13F-HR | 2020-02-13 |
| 13F-HR | 2019-11-15 |
View Grace Capital's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.